Royalty Pharma (RPRX)
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference
Gilead - Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
CACI to Participate in the 16th Annual Wells Fargo Industrials & Materials Conference
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
Carrier Board of Directors Declares Quarterly Cash Dividend
GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Howard Hughes Holdings Announces Closing of Vantage Group Holdings Acquisition
United Natural Foods to Participate at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
Global Ship Lease Announces Newbuilding Orders